Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Joseph Melenhorst

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2011
Is human cell therapy research caught in a mousetrap?A John Barrett, J Joseph Melenhorst
Molecular Endocrinology (Baltimore, Md.)|November 29, 2002
Loss of interleukin 6 results in delayed mammary gland involution: a possible role for mitogen-activated protein kinase and not signal transducer and activator of transcription 3Ling Zhao, J Joseph Melenhorst, Lothar Hennighausen
International Journal of Hematology|June 29, 2020
Next-generation CAR T cells to overcome current drawbacksStefan Lundh, Sayantan Maji, J Joseph Melenhorst
Cytotherapy|April 15, 2018
Toward precision manufacturing of immunogene T-cell therapiesJun Xu, J Joseph Melenhorst, Joseph A Fraietta
Cancers|February 13, 2025
Leveraging Vector-Based Gene Disruptions to Enhance CAR T-Cell EffectivenessBeatriz C Oliveira, Saaurav Bari, J Joseph Melenhorst
Gene Expression Patterns : GEP|June 9, 2004
The proliferation associated nuclear element (PANE1) is conserved between mammals and fish and preferentially expressed in activated lymphoid cellsBrian Bierie, Micah Edwin, J Joseph Melenhorst, et al.
Current Hematologic Malignancy Reports|January 15, 2021
High-Dimensional Immune Monitoring for Chimeric Antigen Receptor T Cell TherapiesSujata Sharma, David Quinn, J Joseph Melenhorst, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 10, 2020
CRISPR/Cas9-Based Gene Engineering of Human Natural Killer Cells: Protocols for Knockout and Readouts to Evaluate Their EfficacyMélanie Lambert, Caroline Leijonhufvud, Filip Segerberg, et al.
Blood|February 28, 2004
Analysis of T-cell repertoire in hepatitis-associated aplastic anemiaJun Lu, Atanu Basu, J Joseph Melenhorst, et al.
British Journal of Haematology|October 3, 2002
Molecular and flow cytometric characterization of the CD4 and CD8 T-cell repertoire in patients with myelodysplastic syndromeJ Joseph Melenhorst, Rhoda Eniafe, Dean Follmann, et al.
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2011
Is human cell therapy research caught in a mousetrap?A John Barrett, J Joseph Melenhorst
Molecular Endocrinology (Baltimore, Md.)|November 29, 2002
Loss of interleukin 6 results in delayed mammary gland involution: a possible role for mitogen-activated protein kinase and not signal transducer and activator of transcription 3Ling Zhao, J Joseph Melenhorst, Lothar Hennighausen
International Journal of Hematology|June 29, 2020
Next-generation CAR T cells to overcome current drawbacksStefan Lundh, Sayantan Maji, J Joseph Melenhorst
Cytotherapy|April 15, 2018
Toward precision manufacturing of immunogene T-cell therapiesJun Xu, J Joseph Melenhorst, Joseph A Fraietta
Cancers|February 13, 2025
Leveraging Vector-Based Gene Disruptions to Enhance CAR T-Cell EffectivenessBeatriz C Oliveira, Saaurav Bari, J Joseph Melenhorst
Gene Expression Patterns : GEP|June 9, 2004
The proliferation associated nuclear element (PANE1) is conserved between mammals and fish and preferentially expressed in activated lymphoid cellsBrian Bierie, Micah Edwin, J Joseph Melenhorst, et al.
Current Hematologic Malignancy Reports|January 15, 2021
High-Dimensional Immune Monitoring for Chimeric Antigen Receptor T Cell TherapiesSujata Sharma, David Quinn, J Joseph Melenhorst, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 10, 2020
CRISPR/Cas9-Based Gene Engineering of Human Natural Killer Cells: Protocols for Knockout and Readouts to Evaluate Their EfficacyMélanie Lambert, Caroline Leijonhufvud, Filip Segerberg, et al.
Blood|February 28, 2004
Analysis of T-cell repertoire in hepatitis-associated aplastic anemiaJun Lu, Atanu Basu, J Joseph Melenhorst, et al.
British Journal of Haematology|October 3, 2002
Molecular and flow cytometric characterization of the CD4 and CD8 T-cell repertoire in patients with myelodysplastic syndromeJ Joseph Melenhorst, Rhoda Eniafe, Dean Follmann, et al.
Pageof 10